On-Demand Webinar: Risk Mitigation in Gene Therapy Clinical Trials Development

Listen to our On-demand webinar as our subject matter experts explores key themes regarding

  • Risk Mitigation in Gene Therapy Clinical Trials
  • Gene Therapy in Diabetes
  • Opportunities and Challenges in Gene Therapy Clinical Trials

Speakers:

Dr. Narendra Chirmule
CEO
SymphonyTech
Dr. Kirk Hammond
Professor of Medicine,
UC San Diego and Founder
Renova Therapeutics
Dr. Atul Gupta 
Associate Vice President,
Medical and Scientific Affairs
Navitas Life Sciences

Please fill this form to view
First Name
✽
Last Name
✽
Business Email
✽
Company
✽
Phone Number
✽
Job Title
✽
Country
✽
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy

© 2021 Navitas Life Sciences | Privacy Policy